We’re delighted to announce that Bristol Myers Squibb , a global biopharmaceutical company, joins The Park Forskaren as a partner in our shared collaboration spaces to expand their presence in the heart of the Stockholm life-science ecosystem.

This marks an exciting addition to Hagastaden’s dynamic community of innovators in life sciences, med-tech, and sustainability.
For decades, Bristol Myers Squibb has been at the forefront of developing transformative treatments for serious conditions such as cancer, https://www.scilifelab.se/ cardiovascular diseases, and immune disorders. Their commitment to advancing science and improving patient outcomes resonates deeply with The Park Forskaren’s mission of fostering collaboration and innovation. Hagastaden’s proximity to top-tier institutions like Karolinska Institutet and SciLifeLab provides an exceptional environment for partnerships and cutting-edge research.

At The Park Forskaren, we’re proud to offer flexible, modern workspaces tailored to the needs of organizations driving global change. We’re excited to welcome Bristol Myers Squibb to our community and look forward to seeing the impact of their work from this new collaboration site. Together, we can shape a healthier future!